Wuhan YZY Biopharma Co Ltd
Status: Publicly traded
Direct answer
Wuhan YZY Biopharma Co Ltd is publicly traded on HKSE under the ticker 2496.HK.
Wuhan YZY Biopharma Co., Ltd. is a biotechnology enterprise specializing in the development of bispecific antibody-based treatments. Its therapeutic focus areas include various cancers, their associated complications, and age-related ophthalmic conditions. The company's extensive portfolio of drug candidates aims to address a wide range of diseases, such as malignant ascites, malignant pleural effusion, various...
Can you invest in Wuhan YZY Biopharma Co Ltd?
Yes. Wuhan YZY Biopharma Co Ltd is publicly traded on HKSE under the ticker 2496.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Wuhan YZY Biopharma Co Ltd
Detailed equity research is provided by MarketSnap.